• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP3参与博来霉素诱导的肺纤维化中上皮-间质转化的调控。

NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.

作者信息

Tian Rui, Zhu Yong, Yao Jiayi, Meng Xiaoxiao, Wang Jinfeng, Xie Hui, Wang Ruilan

机构信息

Department of Critical Care Medicine, Shanghai General Hospital of Nanjing Medical University, Shanghai, China.

Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China.

出版信息

Exp Cell Res. 2017 Aug 15;357(2):328-334. doi: 10.1016/j.yexcr.2017.05.028. Epub 2017 Jun 4.

DOI:10.1016/j.yexcr.2017.05.028
PMID:28591554
Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and irreversible lung disease. Studies have shown that epithelial-mesenchymal transition (EMT) plays an important role in the development of IPF. The NLRP3 inflammasome is reported to be activated and play an important role in many respiratory diseases. However, whether the NLRP3 inflammasome is activated in alveolar epithelial cells as well as the regulatory role of NLRP3 in EMT have not been reported. In this study, we transfected NLRP3 siRNA into A549 and RLE-6TN cells and treated them with bleomycin (BLM) for 24h. Then, we detected the expression of NLRP3 inflammasome-related proteins, EMT-related proteins and transforming growth factor-β1 (TGF-β1) via western blotting, immunofluorescence and real-time quantitative PCR. The mRNA and protein level of NLRP3, ASC and caspase-1 increased after treatment with BLM. The IL-1β levels were significantly decreased after inhibition of NLRP3 and caspase-1. E-cadherin expression increased and α-SMA was reduced in the BLM group when inhibited by NLRP3. The level of TGF-β1 was reduced after NLRP3 silencing. These results indicated that the NLRP3 inflammasome was activated in alveolar epithelial cells and that NLRP3 may regulate EMT through TGF-β1. These results may extend our understanding of the mechanism of pulmonary fibrosis and provide a new therapeutic target for pulmonary fibrosis.

摘要

特发性肺纤维化(IPF)是一种慢性、进行性且不可逆的肺部疾病。研究表明,上皮-间质转化(EMT)在IPF的发展中起重要作用。据报道,NLRP3炎性小体被激活并在许多呼吸系统疾病中起重要作用。然而,NLRP3炎性小体在肺泡上皮细胞中是否被激活以及NLRP3在EMT中的调节作用尚未见报道。在本研究中,我们将NLRP3 siRNA转染到A549和RLE-6TN细胞中,并用博来霉素(BLM)处理24小时。然后,我们通过蛋白质免疫印迹法、免疫荧光法和实时定量PCR检测NLRP3炎性小体相关蛋白、EMT相关蛋白和转化生长因子-β1(TGF-β1)的表达。用BLM处理后,NLRP3、ASC和caspase-1的mRNA和蛋白水平升高。抑制NLRP3和caspase-1后,IL-1β水平显著降低。当被NLRP3抑制时,BLM组中E-钙黏蛋白表达增加而α-平滑肌肌动蛋白减少。NLRP3沉默后,TGF-β1水平降低。这些结果表明NLRP3炎性小体在肺泡上皮细胞中被激活,并且NLRP3可能通过TGF-β1调节EMT。这些结果可能会扩展我们对肺纤维化机制的理解,并为肺纤维化提供新的治疗靶点。

相似文献

1
NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis.NLRP3参与博来霉素诱导的肺纤维化中上皮-间质转化的调控。
Exp Cell Res. 2017 Aug 15;357(2):328-334. doi: 10.1016/j.yexcr.2017.05.028. Epub 2017 Jun 4.
2
Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.丹参酮IIA可改善博来霉素诱导的肺纤维化,并抑制转化生长因子-β(TGF-β)依赖性上皮-间质转化。
J Surg Res. 2015 Jul;197(1):167-75. doi: 10.1016/j.jss.2015.02.062. Epub 2015 Mar 13.
3
Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.雷帕霉素抑制上皮间质转化改善博来霉素诱导的肺纤维化。
Biochem Biophys Res Commun. 2018 Jun 12;500(4):839-845. doi: 10.1016/j.bbrc.2018.04.148. Epub 2018 May 2.
4
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.萝卜硫素通过抑制上皮-间质转化减轻肺纤维化。
BMC Pharmacol Toxicol. 2018 Apr 2;19(1):13. doi: 10.1186/s40360-018-0204-7.
5
Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3.在培养的肺泡上皮细胞系RLE/Abca3中对转化生长因子-β1(TGF-β1)和药物诱导的上皮-间质转化的分析
Drug Metab Pharmacokinet. 2015 Feb;30(1):111-8. doi: 10.1016/j.dmpk.2014.10.007. Epub 2014 Nov 4.
6
Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.组蛋白去乙酰化酶抑制剂可恢复肺泡II型上皮细胞中表面活性蛋白C的表达,并在体内减轻博来霉素诱导的肺纤维化。
Exp Lung Res. 2015;41(8):422-34. doi: 10.3109/01902148.2015.1060275. Epub 2015 Jul 7.
7
Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.maresin 1在体外抑制上皮-间质转化并在体内减轻博来霉素诱导的肺纤维化。
Shock. 2015 Nov;44(5):496-502. doi: 10.1097/SHK.0000000000000446.
8
High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.高迁移率族蛋白盒1通过转化生长因子-β1/ Smad2/3信号通路介导肺纤维化中的上皮-间质转化
J Pharmacol Exp Ther. 2015 Sep;354(3):302-9. doi: 10.1124/jpet.114.222372. Epub 2015 Jun 30.
9
Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition.骨形态发生蛋白4通过抑制NLRP3炎性小体激活和上皮-间质转化改善博来霉素诱导的小鼠肺纤维化。
J Thorac Dis. 2024 Aug 31;16(8):4875-4891. doi: 10.21037/jtd-23-1947. Epub 2024 Aug 28.
10
TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).转化生长因子-β1诱导人肺泡上皮细胞向间充质细胞转化(EMT)。
Respir Res. 2005 Jun 9;6(1):56. doi: 10.1186/1465-9921-6-56.

引用本文的文献

1
Targeting inflammasomes as an immunotherapeutic strategy for cancer.以炎性小体为靶点作为癌症的免疫治疗策略。
J Transl Med. 2025 Jun 8;23(1):634. doi: 10.1186/s12967-025-06665-2.
2
Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations.从NLRP3炎性小体视角看肺纤维化:作用机制与潜在治疗新进展
Front Immunol. 2025 May 5;16:1593729. doi: 10.3389/fimmu.2025.1593729. eCollection 2025.
3
Exploring the mitigating potential of anthocyanin Malvidin in a mouse model of bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and oxidative stress.
通过抑制NLRP3炎性小体激活和氧化应激,探索花青素锦葵色素在博来霉素诱导的小鼠肺纤维化模型中的缓解潜力。
J Inflamm (Lond). 2025 Mar 31;22(1):14. doi: 10.1186/s12950-025-00441-1.
4
Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice.瑞戈非尼作为治疗重症新型冠状病毒肺炎的潜在药物:对小鼠炎性小体激活的抑制作用
FEBS Open Bio. 2025 Mar;15(3):427-435. doi: 10.1002/2211-5463.70002. Epub 2025 Feb 3.
5
MSC-derived exosome ameliorates pulmonary fibrosis by modulating NOD 1/NLRP3-mediated epithelial-mesenchymal transition and inflammation.间充质干细胞衍生的外泌体通过调节NOD 1/NLRP3介导的上皮-间质转化和炎症来改善肺纤维化。
Heliyon. 2024 Dec 26;11(2):e41436. doi: 10.1016/j.heliyon.2024.e41436. eCollection 2025 Jan 30.
6
CircZMYM2 Alleviates TGF-β1-Induced Proliferation, Migration and Activation of Fibroblasts via Targeting miR-199b-5p/KLF13 Axis.环状ZMYM2通过靶向miR-199b-5p/KLF13轴减轻转化生长因子-β1诱导的成纤维细胞增殖、迁移和激活。
Appl Biochem Biotechnol. 2025 May;197(5):2927-2943. doi: 10.1007/s12010-024-05168-y. Epub 2025 Jan 14.
7
DsbA-L activates TGF-β1/SMAD3 signaling and M2 macrophage polarization by stimulating AKT1 and NLRP3 to promote pulmonary fibrosis.Discoidin domain receptor A-L 通过激活 AKT1 和 NLRP3 来激活 TGF-β1/SMAD3 信号通路并促进 M2 巨噬细胞极化,从而促进肺纤维化。
Mol Med. 2024 Nov 23;30(1):228. doi: 10.1186/s10020-024-00983-9.
8
Bleomycin-Induced Fibrosis and the Effectiveness of as a Treatment.博来霉素诱导的纤维化及[具体治疗方法]作为一种治疗手段的有效性。 (注:原文中“as a Treatment”前似乎缺失了具体内容)
J Exp Pharmacol. 2024 Sep 24;16:311-320. doi: 10.2147/JEP.S463899. eCollection 2024.
9
Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition.骨形态发生蛋白4通过抑制NLRP3炎性小体激活和上皮-间质转化改善博来霉素诱导的小鼠肺纤维化。
J Thorac Dis. 2024 Aug 31;16(8):4875-4891. doi: 10.21037/jtd-23-1947. Epub 2024 Aug 28.
10
Forsythiaside A ameliorates bleomycin-induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis.连翘酯苷 A 通过抑制氧化应激和细胞凋亡改善博来霉素诱导的肺纤维化。
Immun Inflamm Dis. 2024 Aug;12(8):e70006. doi: 10.1002/iid3.70006.